Genmab A/S (GMAB) Stock Price & Financial Analysis
Genmab A/S Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Genmab A/S
What is the current stock price for GMAB?
As of the latest trading session, GMAB stock trades at $25.94. The 52-week range is $20.23–$35.43, with a day range of $25.85–$26.19.
What is the P/E ratio for GMAB?
Genmab A/S's trailing P/E ratio is 20.2, meaning investors pay $20.2 for every $1 of annual earnings. The forward P/E is 26.7, reflecting analyst expectations for future earnings. Genmab A/S operates in the Healthcare sector.
Does GMAB pay dividends?
Genmab A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GMAB?
Based on 9 analysts, the consensus for GMAB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of GMAB?
Genmab A/S's market capitalization is $16.56B, classifying it as a large-cap company. Genmab A/S operates in the Healthcare sector within the Biotechnology industry.